Sausheim, Alsace, France Initiative Capital appeared to be the VC, which was created in 1997. The venture was found in Europe in France. The main office of represented VC is situated in the Sausheim.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2004. The fund is generally included in less than 2 deals every year. Opposing the other organizations, this Initiative Capital works on 21 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2013.
We can highlight the next thriving fund investment areas, such as Internet, Biopharma. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Addex Therapeutics, Dartfish, Xigen For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Initiative Capital, startups are often financed by Neomed Management, Ysios Capital, VI Partners AG. The meaningful sponsors for the fund in investment in the same round are VI Partners AG, Ysios Capital, Venture Partners. In the next rounds fund is usually obtained by Ysios Capital, Varuma AG, VI Partners AG.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Brainpad | Japan, Tokyo |
| CEX.IO | England, London, United Kingdom |
| Chengdu High-tech Zone Venture Angel Fund | Chengdu, China, Sichuan |
| CR2 Capital Ventures | Mclean, United States, Virginia |
| Egan-Managed Capital | Boston, Massachusetts, United States |
| Epic Foundation | New York, New York, United States |
| GaoDiLiCai | Beijing, Beijing, China |
| Harvard Business School Angels Chicago | Chicago, Illinois, United States |
| ICV | HaMerkaz, Israel, Ra'anana |
| Imagen Capital Partners | United States, Washington, Woodinville |
| La French Tech | France, Ile-de-France, Paris |
| MC ITE | England, London, United Kingdom |
| Mobi | Estonia, Tartu, Tartumaa |
| Nomura International | England, London, United Kingdom |
| Okamura | Japan, Kanagawa Prefecture, Yokohama |
| Opportunity Finance Network | Pennsylvania, Philadelphia, United States |
| Sacramento Angels | California, Sacramento, United States |
| Serco | Reston, United States, Virginia |
| Shenma Internet Financial Information Service | - |
| Tempo Ventures | California, San Francisco, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Endosense | $40M | 27 Nov 2012 | Geneva, Switzerland | ||
Xigen | $21M | 06 Sep 2005 | Vaud, Switzerland | ||
Addex Therapeutics | $38M | 17 May 2004 | Geneva, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Endosense | $40M | 27 Nov 2012 | Geneva, Switzerland | ||
Xigen | $21M | 06 Sep 2005 | Vaud, Switzerland | ||
Addex Therapeutics | $38M | 17 May 2004 | Geneva, Switzerland |
